Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma. Bajorin DF, Witjes JA, Gschwend JE, Schenker M, et al. N Engl J Med 2021;384:2102-2114.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bajorin DF, Witjes JA, Gschwend JE, Schenker M, et al. Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma. N Engl J Med 2021;384:2102-2114.
PMID: 34077643